Year: 2016
Type: review
Abstract: The term frontotemporal dementia (FTD) describes a clinically, genetically and pathologically diverse group of neurodegenerative disorders. Symptoms of FTD can present in individuals in their 20s through to their 90s, but the mean age at onset is in the sixth decade. The most common presentation is with a change in personality and impaired social conduct (behavioural variant FTD). Less frequently patients present with language problems (primary progressive aphasia). Both of these groups of patients can develop motor features consistent with either motor neuron disease (usually the amyotrophic lateral sclerosis variant) or parkinsonism (most commonly a progressive supranuclear palsy or corticobasal syndrome). In about a third of cases FTD is familial, with mutations in the progranulin, microtubule-associated protein tau and chromosome 9 open reading frame 72 genes being the major causes. Mutations in a number of other genes including TANK-binding kinase 1 are rare causes of familial FTD. This review aims to clarify the often confusing terminology of FTD, and outline the various clinical features and diagnostic criteria of sporadic and familial FTD syndromes. It will also discuss the current major challenges in FTD research and clinical practice, and potential areas for future research. This review clarifies the terminology of frontotemporal dementia (FTD) and summarizes the various clinical features and most recent diagnostic criteria of sporadic and familial FTD syndromes. It also discusses the current major challenges in FTD research and clinical practice, and highlights potential areas for future research.
Source: Journal of Neurochemistry
DOI: 10.1111/jnc.13654
Authors: Ione O. C. Woollacott, Jonathan D. Rohrer
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: frontotemporal dementia, familial frontotemporal dementia, sporadic frontotemporal dementia, behavioral variant frontotemporal dementia, primary progressive aphasia, motor neuron disease, amyotrophic lateral sclerosis, progressive supranuclear palsy, corticobasal syndrome, progranulin, tau protein, TBK1, genetic mutations, diagnostic criteria, clinical features
Open Access status: green
Awards: Developing a methodological framework for trials in presymptomatic neurodegenerative disease - the Presymptomatic Neurodegeneration Initiative (PreNI), The UK GENetic Frontotemporal dementia Initiative (UK GENFI), The GENetic Frontotemporal Dementia Initiative (GENFI): a new multi-centre platform for the study of frontotemporal lobar degeneration, Identifying the role of neuroinflammation in frontotemporal dementia - a pathological and cerebrospinal fluid biomarker study, G8620215749, Developing an evidence base for trials in genetic frontotemporal dementia - measures of disease onset and progression
OpenAlex ID: W2345554415
